Ovid Therapeutics (OVID) Return on Invested Capital (2021 - 2022)
Ovid Therapeutics (OVID) reported Return on Invested Capital of 0.0% for Q4 2022, down 1.0% on a YoY basis from 0.0% in Q4 2021, and up 14.11% quarter-over-quarter from 0.0% in Q3 2022.
Ovid Therapeutics (OVID) Return on Invested Capital (2021 - 2022) Analysis & Trends
Ovid Therapeutics has reported Return on Invested Capital for 2 years, with the latest figure at 0.0% in Q4 2022.
- For the quarter ending Q4 2022, Return on Invested Capital fell 1.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2022 stood at 0.0% (down 1.0% YoY), and the FY2021 full-year result was 0.01%, changed N/A from the prior year.
- Return on Invested Capital for Q4 2022 stood at 0.0%, up from 0.0% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.01% in Q4 2021, with the low at 0.0% in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.01% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -0.01% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ovid Therapeutics | 311.83 Mn | 156.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.01% |